STOCK TITAN

PerkinElmer Board Declares Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Rhea-AI Summary

The Board of Directors of PerkinElmer (NYSE: PKI) has announced a regular quarterly dividend of $0.07 per share. This dividend will be payable on February 10, 2023, to all shareholders registered by the close of business on January 20, 2023. In 2021, PerkinElmer reported revenue of approximately $5 billion and employs over 16,000 individuals worldwide. The company operates in 190 countries and is part of the S&P 500 Index.

Positive
  • Quarterly dividend of $0.07 per share enhances shareholder value.
  • Strong revenue of approximately $5 billion in 2021 reflects solid business performance.
Negative
  • None.

WALTHAM, Mass.--(BUSINESS WIRE)-- The Board of Directors of PerkinElmer, Inc. (NYSE: PKI) today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 10, 2023 to all shareholders of record at the close of business on January 20, 2023.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $5 billion in 2021, has more than 16,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com.

Investor Relations:

Steve Willoughby

(781) 663-5677

steve.willoughby@perkinelmer.com

Media Relations:

Chet Murray

(781) 663-5719

chet.murray@perkinelmer.com

Source: PerkinElmer, Inc.

FAQ

What is the dividend amount declared by PerkinElmer (PKI)?

PerkinElmer declared a quarterly dividend of $0.07 per share.

When will the dividend payment from PerkinElmer (PKI) be made?

The dividend will be payable on February 10, 2023.

What is the record date for PerkinElmer's (PKI) dividend payment?

The record date for the dividend is January 20, 2023.

PERKINELMER INC

NYSE:PKI

PKI Rankings

PKI Latest News

PKI Stock Data

14.46B
109.03M
0.27%
86.26%
2.79%
Diagnostics & Research
Healthcare
Link
United States
Waltham